Johnson & Johnson highlighted growth opportunities within the MedTech sector.

The entities involved

• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • Failures resulted in catastrophic reputational damage for several major companies, while others successfully used safety as a brand differentiator.Tue 09:30
  • AppLovin fears being in Alphabet's crosshairs, while Compass Pathways avoids Johnson & Johnson due to size.Tue 01:20
• Medtech →

  medical education facility founded in 2004 in Indianapolis, U.S

  • Johnson & Johnson's MedTech segment reported sales below expectations and is facing an investigation into federal securities law violations.Wed 18:08

Related events

• Johnson & Johnson MedTech is facing multiple headwinds from China procurement changes, Middle East disruptions, and AbioMed weakness.Wed 13:22
• Johnson & Johnson's MedTech segment missed Q3 estimates, while JNJ's P/E ratio was compared against Eli Lilly and Pfizer.Wed 13:32
• MarketBeat listed Johnson & Johnson, Medtronic plc, and Eli Lilly and Company as top healthcare stocks on October 7, 2026.Oct 7
• Jim Cramer advised against Intuitive Surgical stock, citing competition from Johnson & Johnson.Oct 7
• Analyst targets are being lowered amid new entrants challenging market dominance for medical technology companies.Jul 14